4.4 Article

LDR brachytherapy offers superior tumor control to single-fraction HDR prostate brachytherapy: A prospective study

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

HDR brachytherapy as monotherapy for prostate cancer: A systematic review with meta-analysis

Gustavo Arruda Viani et al.

Summary: This study summarized the biochemical recurrence-free survival and toxicity of high dose brachytherapy in prostate cancer, revealing that total BED, BED per fraction, and number of fractions were key factors associated with biochemical control, providing guidance for choosing the size and number of BRT fractionation.

BRACHYTHERAPY (2021)

Article Oncology

Single-fraction HDR brachytherapy as monotherapy in low and intermediate risk prostate cancer: Outcomes from two clinical trials with and without an MRI-guided boost

Yasir Alayed et al.

Summary: MRI-guided focal boost did not significantly improve local control for localized prostate cancer treated with single-fraction HDR monotherapy. Dosimetric parameters were not significant predictors of biochemical failure. Single-fraction HDR monotherapy should not be recommended outside of clinical trials.

RADIOTHERAPY AND ONCOLOGY (2021)

Article Oncology

PSA outcomes and late toxicity of single-fraction HDR brachytherapy and LDR brachytherapy as monotherapy in localized prostate cancer: A phase 2 randomized pilot study

Thomas Reynaud et al.

Summary: This study evaluated the PSA outcomes, HRQOL, and toxicity of single-fraction High-Dose-Rate brachytherapy (HDRB) and Low-Dose-Rate brachytherapy (LDRB) for prostate cancer patients. The results showed that HDRB resulted in superior HRQOL in the irritative urinary domain compared to LDRB, while the LDRB group had significantly lower PSA nadir and a higher proportion of patients reaching PSA < 0.4 ng/mL.

BRACHYTHERAPY (2021)

Article Oncology

HDR Prostate Brachytherapy

Juanita Crook et al.

SEMINARS IN RADIATION ONCOLOGY (2020)

Article Oncology

Progress in Low Dose Rate Brachytherapy for Prostate Cancer

Patrick W. McLaughlin et al.

SEMINARS IN RADIATION ONCOLOGY (2020)

Article Oncology

Treatment patterns of high-dose-rate and low-dose-rate brachytherapy as monotherapy for prostate cancer

Justin Barnes et al.

JOURNAL OF CONTEMPORARY BRACHYTHERAPY (2019)

Article Radiology, Nuclear Medicine & Medical Imaging

Treatment technique evolution and dosimetry trends over seven years of low dose rate prostate brachytherapy at an Australian institution

Thomas P. Rutten et al.

PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS (2013)

Article Oncology

Long-term results of the M. D. Anderson randomized dose-escalation trial for prostate cancer

Deborah A. Kuban et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)

Article Oncology

Is α/β for prostate tumors really low?

J Fowler et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2001)